News

Norgine Welcomes TGA Registration In Australia Of IFINWIL® (Eflornithine) For Adults And Children Diagnosed With High-Risk Neuroblastoma (HRNB)[1]
In April 2024, Norgine submitted an application for approval of eflornithine in high-risk neuroblastoma (HRNB), via Project Orbis in Australia, Switzerland and the United Kingdom. This milestone ...
Le Lézard1d
Bayer to Unveil Latest NUBEQA® (darolutamide) Data and Prostate Cancer Research at American Urological Association (AUA) 2025 Annual Meeting
Bayer will present new data for NUBEQA® (darolutamide) in prostate cancer at the upcoming American Urological Association (AUA) Annual Meeting taking place in Las Vegas from April 26-29, 2025. These ...
The American Journal of Managed Care2d
Elevated Inflammatory Marker Levels Associated With Increased Overactive Bladder Risk
Systemic immune inflammation index, neutrophil-to-lymphocyte ratio, and systemic inflammation response index levels may offer ...
Immune cell 'messengers' could save crumbling bones—new hope for joint pain sufferers
A recent study has uncovered a potential breakthrough in treating osteonecrosis of the femoral head (ONFH), a debilitating ...